Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.

PLoS Pathog · 2023 · PMC10284421 · PMID 37256916

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The AIDSVAX B/E only group showed a trend towards greater fold decline compared to the ALVAC-HIV/AIDSVAX B/E group ( Fig 2E ), indicating that ALVAC-HIV may drive the longevity of V1V2 IgG responses.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.